Riskpilot← Back to searchSign inGet full accessPharma Bemanning Sverige AB
ABActiveOrg 5592470644Skomakarvägen 20Temporary employment agency activities and other human resource provisions · NACE 7820Est. 202028 employees
Revenue 2025
SEK 21,1M
EBITDA margin
23.0%
+78696% vs 2024
Equity ratio
22.8%
Financial strength
Net profit 2025
SEK 2,9M
+45106% vs 2024
| Revenue | SEK 21,1M | — |
| EBITDA | SEK 4,9M | +78696% |
| Net profit | SEK 2,9M | +45106% |
| Total assets | SEK 12,7M | +39743% |
| Equity | SEK 2,9M | +15114% |
| Employees | 28 | — |
Legal name
Pharma Bemanning Sverige AB
Org number
5592470644
Legal form
Aktiebolag
NACE code
7820 · Temporary employment agency activities and other human resource provisions
Founded
10 mars 2020
Share capital
SEK 25 000
Employees
28 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bemanning och konsultverksamhet med uthyrning av personal samt headhunting till andra bolag inom läkemedelsindustrin och apotek.
Address
Skomakarvägen 20
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 161 | 57 | 5 | 0 | 21 119 |
| Staff expenses | — | −52 | 2 | −0 | −13 300 |
| EBITDA | 41 | −19 | 0 | 6 | 4 857 |
| Depreciation & amort. | −9 | −9 | −9 | — | — |
| EBIT | 32 | −28 | −9 | 6 | 4 857 |
| Net financials | — | — | — | 0 | −1 |
| Profit before tax | 31 | −28 | −9 | 6 | 3 640 |
| Tax | −7 | — | — | — | −752 |
| Net profit | 24 | −28 | −9 | 6 | 2 889 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 59 | 15 | 13 | 32 | 12 729 |
| Equity | 49 | 21 | 13 | 19 | 2 908 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 10 | −7 | 0 | 13 | 8 605 |
| Total debt | 10 | −7 | — | 13 | 8 605 |
EBITDA margin
23.0%
This company
15.8%
Market median
+46% vs market
20212025
Equity ratio
22.8%
This company
38.2%
Market median
-40% vs market
20212025
Return on equity
99.3%
This company
18.4%
Market median
+440% vs market
20212025
Net profit margin
13.7%
This company
8.1%
Market median
+69% vs market
20212025
Asset turnover
1.66×
This company
1.12×
Market median
+48% vs market
20212025
Debt / equity
3.38×
This company
0.62×
Market median
-445% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-03-01 – 2021-04-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2025 | |
| Deputy Board Member | 2022 | |
| Former (5) | ||
| Deputy Board Member | 2020 – 2022 | |
| Deputy Board Member | 2020 – 2022 | |
| Board of Directors | 2022 – 2025 | |
| Board of Directors | 2020 – 2022 | |
| Deputy Board Member | 2020 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Pharma Bemanning Sverige AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Nils Henrik Kristoffer Svensson | Deputy Board Member | 0 companies |
| Lina Anna Elisabeth Nordström | Deputy Board Member | 0 companies |
| Sajjad Rabiee | Board of Directors | 0 companies |
| Zahraa Amer Abdulmalek Dabdawb | Board of Directors | 0 companies |
| Nina Marika Wodzinski | Board of Directors | 0 companies |
| Henrik Daniel Karlsson | Deputy Board Member | 0 companies |
| Walid Kheder Antouan Katan | Deputy Board Member | 0 companies |